- Research works
- 26 ▲ 50% vs 2013–17
- Citations
- 267 10.2 per fractional work
- Top-10% rate
- 2.0% record average 16.5%
- Open access
- 61% world 28%
Not ranked overall: Patara Pharma (United States) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Chemistry, 4.3×. Every wedge is a field page.
Which keywords describe research at Patara Pharma (United States)?
By fractional works in all years, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Chemotherapy, Inflammation, Type 2 Diabetes, Clinical Guidelines, Heart Failure and Diabetes.
- Antimicrobial Resistance
- Complications
- Oxidative Stress
- Cardiovascular Outcomes
- Treatment
- Immunotherapy
- Diabetes
- Type 2 Diabetes
- Insulin Therapy
- Epidemiology
- Inflammation
- Glycemic Control
- Chemotherapy
- Clinical Guidelines
- Heart Failure
- Pathogenesis
- Apoptosis
- Glucose Control
- Cardiovascular Disease
- Molecular Characterization
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 20 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 20 words, with their numbers
- Inflammation2▲ 3.8×10 topics
- Epidemiology2▲ 2.0×12 topics
- Glycemic Control2▲ 58×3 topics
- Insulin Therapy2▲ 72×3 topics
- Chemotherapy2▲ 9.6×5 topics
- Type 2 Diabetes2▲ 34×2 topics
- Clinical Guidelines2▲ 20×2 topics
- Diabetes2▲ 12×6 topics
- Heart Failure2▲ 14×2 topics
- Immunotherapy2▲ 8.7×4 topics
- Pathogenesis1▲ 9.4×5 topics
- Treatment1▲ 4.2×6 topics
- Apoptosis1▲ 13×5 topics
- Cardiovascular Outcomes1▲ 118×1 topic
- Glucose Control1▲ 118×1 topic
- Oxidative Stress1▲ 2.6×7 topics
- Cardiovascular Disease1▲ 4.0×4 topics
- Complications1▲ 9.1×2 topics
- Molecular Characterization1▲ 23×3 topics
- Antimicrobial Resistance1▲ 15×2 topics
Which research topics does Patara Pharma (United States) publish most on?
By volume in 2022–2025: Bladder and Urothelial Cancer Treatments, Antibiotics Pharmacokinetics and Efficacy, Cancer Immunotherapy and Biomarkers and Gastrointestinal motility and disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Bladder and Urothelial Cancer Treatments Surgery 1 works
- 2 Antibiotics Pharmacokinetics and Efficacy Pharmacology 1 works
- 3 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 4 Gastrointestinal motility and disorders Gastroenterology 0 works
- 5 Gastroesophageal reflux and treatments Gastroenterology 0 works
- 6 Helicobacter pylori-related gastroenterology studies Surgery 0 works
- 7 Synthesis and biological activity Organic Chemistry 0 works
- 8 Chemotherapy-related skin toxicity Dermatology 0 works
- 9 Growth Hormone and Insulin-like Growth Factors Endocrinology, Diabetes and Metabolism 0 works
- 10 Urinary Tract Infections Management Epidemiology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Patara Pharma (United States)'s research output changed?
Output in 2018–2022 was 50% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in San Diego
- University of California San Diego
- San Diego State University
- Scripps Research Institute
- University of San Diego
- University of California San Diego Medical Center
- General Atomics (United States)
- Scripps Health
- Naval Medical Center San Diego
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.